| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/24/2014 | WO2014059548A1 Methods and compositions for assessing spermatozoa in a semen sample |
| 04/24/2014 | WO2014059544A1 Transgenic cells for identifying gpcr signaling compound modulating gpcr signaling pathway and screening method thereof |
| 04/24/2014 | WO2014033627A3 Simplified extraction methods for the rapid determination of species content of adipose tissue based on the detection of tni in immunoassays |
| 04/24/2014 | WO2014031668A3 Antibodies to quetiapine and use thereof |
| 04/24/2014 | WO2014031662A3 Antibodies to olanzapine and use thereof |
| 04/24/2014 | WO2014020502A3 Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2) |
| 04/24/2014 | WO2014013456A3 Surface supported liposome nanoarrays as biomimetic sensors |
| 04/24/2014 | WO2014009929A3 Scalable liposome microarray screening |
| 04/24/2014 | WO2013188124A9 Methods for predicting dynamic sag using viscometer/rheometer data |
| 04/24/2014 | WO2013187765A3 Methods, reagents and kits for detecting minimal residual disease |
| 04/24/2014 | WO2013185193A8 Method for producing and obtaining variable domains of anti-digoxin monoclonal antibody fab fragment using the molecular biology cloning technique |
| 04/24/2014 | WO2013122611A3 New method for decontamination and processing of clinical specimens from a patient |
| 04/24/2014 | WO2013049362A8 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis |
| 04/24/2014 | WO2012142450A3 Quality control method and apparatus for automated analyses of biologic fluid sample |
| 04/24/2014 | WO2012134961A3 System and method for forest management using stand development performance as measured by leaf area index |
| 04/24/2014 | WO2012122372A3 Methods of detecting antibodies specific for denatured hla antigents |
| 04/24/2014 | WO2012082678A3 Tissue processor |
| 04/24/2014 | WO2012068474A3 A high-throughput asseessment method for contact hypersensitivity |
| 04/24/2014 | WO2012044933A8 B and t lymphocyte attenuator marker for use in adoptive t-cell therapy |
| 04/24/2014 | US20140115730 Apparatuses and Methods for Evaluating and Sorting Pollen and Plants |
| 04/24/2014 | US20140115727 NOVEL ANTI-cMET ANTIBODY |
| 04/24/2014 | US20140114581 Using game theory in identifying compounds that bind to targets |
| 04/24/2014 | US20140114206 Methods For Detecting Bacterial Infections |
| 04/24/2014 | US20140114056 Evaluating heparin preparations |
| 04/24/2014 | US20140113979 Compositions and Methods for Detecting Cancer |
| 04/24/2014 | US20140113972 Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic status |
| 04/24/2014 | US20140113913 Mcl-1 as a therapeutic target in scffbw7 deficient neoplasm |
| 04/24/2014 | US20140113912 Treatment and management of cns disorders |
| 04/24/2014 | US20140113905 Inhibition of phosphorylation of pras40, gsk3-beta or p70s6k1 as a marker for tor kinase inhibitory activity |
| 04/24/2014 | US20140113904 Treatment of cancer with tor kinase inhibitors |
| 04/24/2014 | US20140113885 Assays and methods of treatment relating to vitamin d insufficiency |
| 04/24/2014 | US20140113876 Biomarkers for assessing treatment of sialic acid deficiency diseases and conditions |
| 04/24/2014 | US20140113873 Chitin binding proteins and methods of use |
| 04/24/2014 | US20140113872 Novel agonists and antagonists of the urotensinergic system |
| 04/24/2014 | US20140113857 Targeting deregulated wnt signaling in cancer using stabilized alpha-helices of bcl-9 |
| 04/24/2014 | US20140113840 Analyte detection system with cleaning phase and renewable liquid sensing material and methods therefore |
| 04/24/2014 | US20140113838 Microfluidic Assay Apparatus and Methods of Use |
| 04/24/2014 | US20140113837 System and method for determining individualized medical intervention for a disease state |
| 04/24/2014 | US20140113836 Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid |
| 04/24/2014 | US20140113835 Chemically-defined arrays for screening cell-substrate interactions |
| 04/24/2014 | US20140113834 Hybridoma clones and monoclonal antibodies to ing4 |
| 04/24/2014 | US20140113833 Use of multiple risk predictors for diagnosis of cardiovascular disease |
| 04/24/2014 | US20140113832 Engineered thioredoxin-like fold proteins |
| 04/24/2014 | US20140113831 Antibody screening methods |
| 04/24/2014 | US20140113830 Azoline Compound and Azole Compound Library and Method for Producing Same |
| 04/24/2014 | US20140113387 Method of inhibiting nonspecific reaction in pivka-ii assay reagent |
| 04/24/2014 | US20140113385 Compositions and Methods for Identifying Single Antigens or Other Molecules in Cell Preparations |
| 04/24/2014 | US20140113384 Sensor integration in lateral flow immunoassays and its applications |
| 04/24/2014 | US20140113379 Apparatus, System and Method for Consumer Detection of Contaminants in Food Stuffs |
| 04/24/2014 | US20140113366 Microfluidic system for controlling the concentration of molecules for stimulating a target |
| 04/24/2014 | US20140113358 Systems and Methods for Focusing Particles |
| 04/24/2014 | US20140113325 Use of fluorescent saccharide-based derivative |
| 04/24/2014 | US20140113324 System and method for deforming and analyzing particles |
| 04/24/2014 | US20140113320 Methods for determining the risk of prenatal complications |
| 04/24/2014 | US20140113319 Methods for determining the risk of prenatal complications |
| 04/24/2014 | US20140113318 Novel Biomarkers |
| 04/24/2014 | US20140113317 Polyclonal antibodies to cloned fungal polypeptide targets |
| 04/24/2014 | US20140113316 Device, method and kit for the detection of different markers in different cellular or molecular types and their quantifications |
| 04/24/2014 | US20140113315 Cell separation method using a release system for cell-antibody-substrate conjugates containing a polyethylene glycol spacer unit |
| 04/24/2014 | US20140113314 Two Pore Channels as a Therapeutic Target to Protect Against Myocardial Ischemia and as an Adjuvant in Cardiac Surgery |
| 04/24/2014 | US20140113313 Method of diagnosing adolescent idiopathic scoliosis |
| 04/24/2014 | US20140113311 Agglutination enhancer |
| 04/24/2014 | US20140113310 Cancer detection markers |
| 04/24/2014 | US20140113308 Mcam as a biomarker for fluid homeostasis |
| 04/24/2014 | US20140113307 Method for analyzing protein-protein interaction on single-molecule level in cell environment, and method for measuring density of protein activated in cytosol |
| 04/24/2014 | US20140113306 Diagnostic and screening methods for inflammation |
| 04/24/2014 | US20140113305 Exosomes and diagnostic biomarkers |
| 04/24/2014 | US20140113288 Methods of identifying risk of preeclampsia and pregnancy-related disorders |
| 04/24/2014 | US20140113285 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
| 04/24/2014 | US20140113283 High-speed screening apparatus for a raman analysis-based high-speed multiple drug |
| 04/24/2014 | US20140113280 Device for detection of molecules in biological fluids |
| 04/24/2014 | US20140113006 Methods of determining whether the wnt signaling pathway is upregulated in a tumor |
| 04/24/2014 | US20140112977 Allogeneic autophagosome-enriched composition for the treatment of disease |
| 04/24/2014 | US20140112955 Biomarkers of immunotherapy efficacy |
| 04/24/2014 | US20140112936 Methods of neutralizing viral infection |
| 04/24/2014 | US20140112929 Tumour necrosis factor receptor 1 antagonists |
| 04/24/2014 | US20140112919 Interleukin-10 antibodies |
| 04/24/2014 | US20140112917 Diagnostic and therapeutic methods and compositions involving pten and breast cancer |
| 04/24/2014 | US20140112915 IL-18 binding molecules |
| 04/24/2014 | US20140112912 Diagnosis and treatment of autoantibody-mediated heart disease |
| 04/24/2014 | US20140112872 Magnetic relaxometry using magnetization and measurement fields |
| 04/24/2014 | US20140112864 Anti-Mucin Antibodies for Early Detection and Treatment of Pancreatic Cancer |
| 04/24/2014 | US20140110590 Conveyor system and measuring device for determining water content of a construction material |
| 04/24/2014 | US20140109656 Apparatus for Measurement of Liquid Oil Products |
| 04/24/2014 | US20140109649 Device and method for determining carbon dioxide content of air |
| 04/24/2014 | US20140109648 Operating Method for a Gas Sensor and Gas Sensor |
| 04/24/2014 | DE102012219156A1 Integriertes mikrofluidisches bauteil zur anreicherung und extraktion biologischer zellbestandteile Integrated microfluidic component for enrichment and extraction of biological cell consisted share |
| 04/24/2014 | DE102012020912A1 Method for supporting preservation of insect population, involves determining desired insect population in predetermined area, which is derived from actual insect population in predetermined area and difference in insect population |
| 04/23/2014 | EP2722675A1 Method of measuring blood coagulation time to detect lupus anticoagulants |
| 04/23/2014 | EP2722674A1 Method for detecting lupus anticoagulants |
| 04/23/2014 | EP2722673A1 Improved method of mapping glycans of glycoproteins |
| 04/23/2014 | EP2722672A1 Assay method using magnetic silica particles and reagent for said assay method |
| 04/23/2014 | EP2722671A1 Improving glass bead flow rates to facilitate immunodiagnostic test element manufacture |
| 04/23/2014 | EP2722670A1 Method for analyzing mucin 1 using probe capable of binding to 3´-sulfonated core 1 carbohydrate chain, and method for detecting or monitoring breast cancer |
| 04/23/2014 | EP2722669A1 Method and device for detecting illegal drugs |
| 04/23/2014 | EP2722668A1 High throughput screening of ion channels |
| 04/23/2014 | EP2722665A1 Surface plasmon-field enhanced fluorescence spectroscopic measurement method and surface plasmon-field enhanced fluorescence spectroscopic measurement device |
| 04/23/2014 | EP2722400A2 Methods of using biomarkers |
| 04/23/2014 | EP2722342A1 Methods and compositions for the treatment of pancreatic cancer |
| 04/23/2014 | EP2722059A2 Photodynamic diagnostics of tissue fluids caused by oncological pathology |